Long-Term Liabilities to Equity: Orthofix Corp (OFIX)

Official company branding of Orthofix Corp (OFIX)

The market valuation chart for Orthofix Medical Inc. (OFIX) on the GURU.Markets platform illustrates a business whose bone stimulators and spinal systems have reached maturity, with current growth driven by integration processes. The current metric stands at 0.61. Profitability is tied to the volume of scheduled procedures, synergies with SeaSpine, and margins on consumables. Patent protection, FDA certification, and extensive physician training create high barriers to entry.

Orthofix International (OFIX): Long-Term Debt to Capital from 07/04/2022 to 10/28/2026
Core merchandise of Orthofix Medical Inc.

When constructing a long-term portfolio, screening focuses on the stability of the financing structure via the ratio of liabilities with a maturity of over one year to equity. This metric measures the business's dependence on external borrowing, which for Orthofix Medical Inc. (OFIX) and its diversified implant portfolio signifies a balance between expansion and solvency, as clearly reflected by the long-term debt-to-equity history on GURU.Markets.

Direct competitors

Ratio of Long-Term Indebtedness to Capital BSX|EW - Long-Term Debt to Equity|Long-Term Liabilities to Equity ResMed Corporation (RMD)|PODD: Long-Term Debt to Capital|Long-Term Liabilities to Capital Zimmer ZBH|COO: Long-Term Debt to Capital|ALGN - Long-Term Debt to Equity Ratio|Globus Medical Corp - Long-Term Debt to Capital|TransMedics Group, Inc. (TMDX) - Ratio of Long-Term Indebtedness to Capital|ATEC (Alphatec Holdings, Inc.) - Long-Term Debt to Capital|Long-Term Debt to Capital AORT|Long-Term Debt to Equity Enovis (ENOV)|Long-Term Debt to Equity Integra LifeSciences Corp (IART)|Long-Term Debt to Capital ESTA|BBNX - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Ratio IRADIMED CORPORATION|EMBC - Long-Term Liabilities to Equity|Long-Term Debt to Capital TNDM|AxoGen Inc (AXGN) - Long-Term Liabilities to Capital|Long-Term Debt to Capital SI-BONE Corp (SIBN)|Long-Term Debt to Capital Ratio Bioventus Global (BVS)|OrthoPediatrics Corp. (KIDS) - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient TMCI (treace.com)|Strata Critical Medical - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio Carlsmed, Inc. CARL|RXST (RxSight Corp) - Long-Term Debt to Capital|CLPT - Long-Term Liabilities to Capital|Long-Term Debt to Capital Stereotaxis, Inc.|neurostar.com (STIM) - Long-Term Debt to Capital Ratio|SGHT: Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital Orchestra BioMed Inc.|Long-Term Debt to Capital ANIK (Anika Therapeutics)|Long-Term Debt to Equity Ratio InspireMD Inc. (NSPR)|Long-Term Debt to Capital ZJYL (Jin Medical)|Vivani Medical Inc - Long-Term Debt to Capital|XTNT - Long-Term Debt to Equity|NeuroOne (NMTC) - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio modular-medical.com MODD|Myomo Inc (MYO) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital COCH (Envoy Medical, Inc.)|Long-Term Liabilities to Capital VVOS|NVNO: Long-Term Debt to Equity|Long-Term Indebtedness to Equity sintx.com SINT|Long-Term Debt to Equity Ratio TNON (Tenon Medical, Inc)|Long-Term Debt to Capital Lifeward Ltd. LFWD|Long-Term Debt to Capital AMIX (Autonomix)|IVF: Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Bone Biologics Corp (BBLG)|AXNX (Axonics Inc.) - Long-Term Liabilities to Equity|Long-Term Debt to Equity BIOL|Long-Term Debt to Equity Ratio Dynatronics Corp.|Paragon 28, Inc. - Long-Term Debt to Capital|Long-Term Liabilities to Capital INVO (invobioscience.com)